Showing results (11-20 of 332) with videos related to

Sort By:
Pageof 34
Genetics in Medicine : Official Journal of the American College of Medical Genetics|November 4, 2008
Economic methods for valuing the outcomes of genetic testing: beyond cost-effectiveness analysisScott D Grosse, Sarah Wordsworth, Katherine Payne
International Journal of Technology Assessment in Health Care|September 21, 2006
Women's preferences for cervical cancer screening: a study using a discrete choice experimentSarah Wordsworth, Mandy Ryan, Diane Skåtun, et al.
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|January 19, 2011
Treating pneumonia in critical care in the United Kingdom following failure of initial antibiotic: a cost-utility analysis comparing meropenem with piperacillin/tazobactamSteven J Edwards, Sarah Wordsworth, Mike J Clarke
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|March 18, 2005
Collecting unit cost data in multicentre studies. Creating comparable methodsSarah Wordsworth, Anne Ludbrook, Fergus Caskey, et al.
Pharmacoeconomics|April 30, 2017
Does the Public Prefer Health Gain for Cancer Patients? A Systematic Review of Public Views on Cancer and its CharacteristicsLiz Morrell, Sarah Wordsworth, Sian Rees, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|May 30, 2007
Eliciting expert opinion for economic models: an applied exampleJosé Leal, Sarah Wordsworth, Rosa Legood, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|February 16, 2018
Are whole-exome and whole-genome sequencing approaches cost-effective? A systematic review of the literatureKatharina Schwarze, James Buchanan, Jenny C Taylor, et al.
European Journal of Human Genetics : EJHG|July 20, 2007
Risk estimation for familial breast cancer: improving the system of counsellingHelen Gregory, Sarah Wordsworth, Barbara Gibbons, et al.
BMC Health Services Research|September 1, 2017
Cancer drug funding decisions in Scotland: impact of new end-of-life, orphan and ultra-orphan processesLiz Morrell, Sarah Wordsworth, Howell Fu, et al.
Plos One|December 19, 2017
The EQ-5D-5L is a valid approach to measure health related quality of life in patients undergoing bariatric surgeryJilles M Fermont, Jane M Blazeby, Chris A Rogers, et al.
Pageof 34